Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that an analyst meeting is scheduled on 20th and 25th June 2025 as per the details enclosed.
The above information is a part of company’s filings submitted to BSE.